BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sekula P, Mallett S, Altman DG, Sauerbrei W. Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles. PLoS One 2017;12:e0178531. [PMID: 28614415 DOI: 10.1371/journal.pone.0178531] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Will TR, Proaño SB, Thomas AM, Kunz LM, Thompson KC, Ginnari LA, Jones CH, Lucas SC, Reavis EM, Dorris DM, Meitzen J. Problems and Progress regarding Sex Bias and Omission in Neuroscience Research. eNeuro 2017;4:ENEURO. [PMID: 29134192 DOI: 10.1523/ENEURO.0278-17.2017] [Cited by in Crossref: 53] [Cited by in F6Publishing: 38] [Article Influence: 10.6] [Reference Citation Analysis]
2 Iafolla MAJ, Picardo S, Aung K, Hansen AR. Systematic review and REMARK scoring of renal cell carcinoma prognostic circulating biomarker manuscripts. PLoS One 2019;14:e0222359. [PMID: 31639128 DOI: 10.1371/journal.pone.0222359] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Kempf E, de Beyer JA, Cook J, Holmes J, Mohammed S, Nguyên TL, Simera I, Trivella M, Altman DG, Hopewell S, Moons KGM, Porcher R, Reitsma JB, Sauerbrei W, Collins GS. Overinterpretation and misreporting of prognostic factor studies in oncology: a systematic review. Br J Cancer 2018;119:1288-96. [PMID: 30353050 DOI: 10.1038/s41416-018-0305-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
4 Noordhuis MG, Kop EA, van der Vegt B, Langendijk JA, van der Laan BFAM, Schuuring E, de Bock GH. Biological tumor markers associated with local control after primary radiotherapy in laryngeal cancer: A systematic review. Clin Otolaryngol 2020;45:486-94. [PMID: 32246586 DOI: 10.1111/coa.13540] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Kristiansen G. Markers of clinical utility in the differential diagnosis and prognosis of prostate cancer. Mod Pathol 2018;31:143-55. [DOI: 10.1038/modpathol.2017.168] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
6 Dizdarevic E, Hansen T, Jakobsen A. The Prognostic Importance of ctDNA in Rectal Cancer: A Critical Reappraisal. Cancers 2022;14:2252. [DOI: 10.3390/cancers14092252] [Reference Citation Analysis]
7 Chen Z, Zhan Y, Chi J, Guo S, Zhong X, He A, Zheng J, Gong Y, Li X, Zhou L. Using microRNAs as Novel Predictors of Urologic Cancer Survival: An Integrated Analysis. EBioMedicine 2018;34:94-107. [PMID: 30037718 DOI: 10.1016/j.ebiom.2018.07.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
8 Sauerbrei W, Haeussler T. Comment on 'BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses'. Br J Cancer 2018;118:1152-3. [PMID: 29540774 DOI: 10.1038/s41416-018-0023-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 de Vries EGE, Kist de Ruijter L, Lub-de Hooge MN, Dierckx RA, Elias SG, Oosting SF. Integrating molecular nuclear imaging in clinical research to improve anticancer therapy. Nat Rev Clin Oncol 2019;16:241-55. [PMID: 30479378 DOI: 10.1038/s41571-018-0123-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
10 Doussau A, Vinarov E, Barsanti-Innes B, Kimmelman J. Comparison between protocols and publications for prognostic and predictive cancer biomarker studies. Clin Trials 2020;17:61-8. [PMID: 31588779 DOI: 10.1177/1740774519876912] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 de Jong Y, van der Willik EM, Milders J, Voorend CGN, Morton RL, Dekker FW, Meuleman Y, van Diepen M. A meta-review demonstrates improved reporting quality of qualitative reviews following the publication of COREQ- and ENTREQ-checklists, regardless of modest uptake. BMC Med Res Methodol 2021;21:184. [PMID: 34511068 DOI: 10.1186/s12874-021-01363-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Sauerbrei W, Haeussler T, Balmford J, Huebner M. Structured reporting to improve transparency of analyses in prognostic marker studies. BMC Med 2022;20:184. [PMID: 35546237 DOI: 10.1186/s12916-022-02304-5] [Reference Citation Analysis]
13 Irvine AF, Waise S, Green EW, Stuart B. A non-linear optimisation method to extract summary statistics from Kaplan-Meier survival plots using the published P value. BMC Med Res Methodol 2020;20:269. [PMID: 33126853 DOI: 10.1186/s12874-020-01092-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Sauerbrei W, Bland M, Evans SJW, Riley RD, Royston P, Schumacher M, Collins GS. Doug Altman: Driving critical appraisal and improvements in the quality of methodological and medical research. Biom J 2021;63:226-46. [PMID: 32639065 DOI: 10.1002/bimj.202000053] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Zamanipoor Najafabadi AH, Ramspek CL, Dekker FW, Heus P, Hooft L, Moons KGM, Peul WC, Collins GS, Steyerberg EW, van Diepen M. TRIPOD statement: a preliminary pre-post analysis of reporting and methods of prediction models. BMJ Open 2020;10:e041537. [PMID: 32948578 DOI: 10.1136/bmjopen-2020-041537] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
16 Hadler-Olsen E, Wirsing AM. Tissue-infiltrating immune cells as prognostic markers in oral squamous cell carcinoma: a systematic review and meta-analysis. Br J Cancer 2019;120:714-27. [PMID: 30808992 DOI: 10.1038/s41416-019-0409-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 10.0] [Reference Citation Analysis]
17 Sauerbrei W, Royston P. Investigating treatment-effect modification by a continuous covariate in IPD meta-analysis: an approach using fractional polynomials. BMC Med Res Methodol 2022;22:98. [PMID: 35382744 DOI: 10.1186/s12874-022-01516-w] [Reference Citation Analysis]
18 Peng X, Nie X, Ni X. Better reporting quality for improved pediatric investigation: Application of health research reporting guidelines. Pediatr Investig 2017;1:9-12. [PMID: 32851210 DOI: 10.1002/ped4.12009] [Reference Citation Analysis]
19 El Bairi K, Al Jarroudi O, Afqir S. Practical Tools and Guidelines for Young Oncologists From Resource-Limited Settings to Publish Excellence and Advance Their Career. JCO Glob Oncol 2021;7:1668-81. [PMID: 34910583 DOI: 10.1200/GO.21.00310] [Reference Citation Analysis]
20 Draht MXG, Goudkade D, Koch A, Grabsch HI, Weijenberg MP, van Engeland M, Melotte V, Smits KM. Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review. Clin Epigenetics 2018;10:35. [PMID: 29564023 DOI: 10.1186/s13148-018-0461-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
21 Groot OQ, Ogink PT, Lans A, Twining PK, Kapoor ND, DiGiovanni W, Bindels BJJ, Bongers MER, Oosterhoff JHF, Karhade AV, Oner FC, Verlaan JJ, Schwab JH. Machine learning prediction models in orthopedic surgery: A systematic review in transparent reporting. J Orthop Res 2021. [PMID: 33734466 DOI: 10.1002/jor.25036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Mamlouk GM, Dorris DM, Barrett LR, Meitzen J. Sex bias and omission in neuroscience research is influenced by research model and journal, but not reported NIH funding. Front Neuroendocrinol 2020;57:100835. [PMID: 32070715 DOI: 10.1016/j.yfrne.2020.100835] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
23 Sauerbrei W, Taube SE, McShane LM, Cavenagh MM, Altman DG. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration. J Natl Cancer Inst. 2018;110:803-811. [PMID: 29873743 DOI: 10.1093/jnci/djy088] [Cited by in Crossref: 136] [Cited by in F6Publishing: 133] [Article Influence: 45.3] [Reference Citation Analysis]
24 Heus P, Damen JAAG, Pajouheshnia R, Scholten RJPM, Reitsma JB, Collins GS, Altman DG, Moons KGM, Hooft L. Poor reporting of multivariable prediction model studies: towards a targeted implementation strategy of the TRIPOD statement. BMC Med 2018;16:120. [PMID: 30021577 DOI: 10.1186/s12916-018-1099-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]